相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 英文名:
CK-1827452
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
873697-71-3
- 规格:
10 mM * 1 mL/1 mg/5 mg/10 mg/25 mg/50 mg
| 规格: | 10 mM * 1 mL | 产品价格: | ¥883.0 |
|---|---|---|---|
| 规格: | 1 mg | 产品价格: | ¥389.0 |
| 规格: | 5 mg | 产品价格: | ¥1000.0 |
| 规格: | 10 mg | 产品价格: | ¥1600.0 |
| 规格: | 25 mg | 产品价格: | ¥2900.0 |
| 规格: | 50 mg | 产品价格: | ¥4600.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
Omecamtiv mecarbil
CAS No. : 873697-71-3
MCE 国际站:Omecamtiv mecarbil
产品活性:Omecamtiv mecarbil (CK-1827452) 是一种心脏特异性的肌球蛋白 (cardiac myosin) 激活剂。
研究领域:Cytoskeleton
作用靶点:Myosin
In Vitro: Omecamtiv mecarbil (10 μM) reduces the maximal ATPase (kcat) 4.5-fold and dramatically reduces the actin concentration at which ATPase is half-maximal (KATPase) 30-fold. The Omecamtiv mecarbil-induced inhibition of the actin-activated ATPase is evaluated in a concentration-dependent manner to determine the EC50 (0.52 ± 0.10 μM). Omecamtiv mecarbil does not change the overall actin affinity. Omecamtiv mecarbil traps a population of myosin heads in a weak actin affinity state with slow product release. Omecamtiv mecarbil can reduce the actin sliding velocity more than 100-fold in the in vitro motility assay.
In Vivo: Omecamtiv mecarbil (100-1000 ng/mL) demonstrates concentration-dependent increases in FS in Sprague?Dawley rats model. Omecamtiv mecarbil demonstrates good PK parameters in both rats (Sprague?Dawley) and dogs (Beagle) with clearances of 22 and 7.2 mL/min/kg, volumes of 3.5 and 3.6 L/kg, and bioavailabilities (F%) of 100 and 80%, respectively. Omecamtiv mecarbil does not affect the phosphorylation status of myofilament proteins in both WT and KO hearts as shown by the absence of significant differences between pre and post Omecamtiv mecarbil samples within WT and KO groups, or affect the force generation at maximal Ca2+ activation (pCa 4.5) in any of the groups. Omecamtiv mecarbil increases the responsiveness of the cardiac myofilaments to Ca2+ at submaximal Ca2+-activations.
相关产品:Covalent Screening Library Plus | Drug Repurposing Compound Library Plus | Clinical Compound Library Plus | Bioactive Compound Library Plus | Clinical Compound Library | Drug Repurposing Compound Library | Covalent Screening Library | Anti-Cardiovascular Disease Compound Library | Anti-COVID-19 Compound Library | Cytoskeleton Compound Library | Targeted Diversity Library | Heterocyclic Compound Library | Highly Selective Activators Library | (-)-Blebbistatin | ML-7 hydrochloride | Mavacamten | W-7 hydrochloride | MS-444 | Danicamtiv | Aficamten | HA-100 | ML-9 | MLCK inhibitor peptide 18 | para-Nitroblebbistatin | Biacetyl monoxime | BTS | Pentachloropseudilin | ATM-3507 trihydrochloride | Sevasemten | 16-38-Thymosin β4 (cattle) (TFA) | MPH-220 | Myosin V-IN-1 | JB002 | JB061 | JB062 | Kemptamide
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料

















